Requests that the FDA to determine whether CARAFATE® (sucralfate) oral suspension 1 g/10 mL; NDA 019183 of ABBVIE INC has been voluntarily withdrawn from sale.
🏛 Food and Drug Administration (FDA)FDA-2026-P-7537
Documents
3
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jul 7, 2026No comment period
- Supporting & Related Material· Jul 7, 2026